[1] Vanderver, A., Prust, M., Tonduti, D., Mochel, F., Hussey, H. M., Helman, G., Garbern, J., Eichler, F., Labauge, P., Aubourg, P., Rodriguez, D., Patterson, M. C., van Hove, J. L. K., Schmidt, J., Wolf, N. I., Boespflug-Tanguy, O., Schiffmann, R., & van der Knaap, M. S. (2015). Case definition and classification of leukodystrophies and leukoencephalopathies. Molecular Genetics and Metabolism, 114(4), 494–500. https://doi.org/10.1016/j.ymgme.2015.01.006
[2] Moser, H. (1997). Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain, 120(8), 1485–1508. https://doi.org/10.1093/brain/120.8.1485
[3] van der Knaap, M. S., & Bugiani, M. (2017). Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathologica, 134(3), 351–382. https://doi.org/10.1007/s00401-017-1739-1
[4] Schiffmann, R., & van der Knaap, M. S. (2009). Invited Article: An MRI-based approach to the diagnosis of white matter disorders. Neurology, 72(8), 750–759. https://doi.org/10.1212/01.wnl.0000343049.00540.c8
[5] Weerakkody Y, Alwalid O, Yap J, et al. Pelizaeus-Merzbacher disease. Reference article, Radiopaedia.org (Accessed on 17 Dec 2024) https://radiopaedia.org/articles/7286
[6] Ceravolo, G., Zhelcheska, K., Squadrito, V., Pellerin, D., Gitto, E., Hartley, L., & Houlden, H. (2024). Update on leukodystrophies and developing trials. Journal of Neurology, 271(1), 593–605. https://doi.org/10.1007/s00415-023-11996-5
[7] Resende, L. L., de Paiva, A. R. B., Kok, F., da Costa Leite, C., & Lucato, L. T. (2019). Adult Leukodystrophies: A Step-by-Step Diagnostic Approach. RadioGraphics, 39(1), 153–168. https://doi.org/10.1148/rg.2019180081
[8] Weerakkody Y, Sharma R, Yap J, et al. X-linked adrenoleukodystrophy. Reference article, Radiopaedia.org (Accessed on 17 Dec 2024) https://doi.org/10.53347/rID-10259
[9] Melhem, E. R., Loes, D. J., Georgiades, C. S., Raymond, G. v, & Moser, H. W. (2000). X-linked Adrenoleukodystrophy: The Role of Contrast-enhanced MR Imaging in Predicting Disease Progression. American Journal of Neuroradiology, 21(5), 839. http://www.ajnr.org/content/21/5/839.abstract
[10] Messing, A., Brenner, M., Feany, M. B., Nedergaard, M., & Goldman, J. E. (2012). Alexander Disease. The Journal of Neuroscience, 32(15), 5017–5023. https://doi.org/10.1523/JNEUROSCI.5384-11.2012
[11] Gaillard F, Sharma R, Campos A, et al. Vanishing white matter disease. Reference article, Radiopaedia.org (Accessed on 17 Dec 2024) https://doi.org/10.53347/rID-20903
[12] Kurda D, Sharma R, Deng F, et al. Leukoencephalopathy with calcifications and cysts. Reference article, Radiopaedia.org (Accessed on 17 Dec 2024) https://doi.org/10.53347/rID-39114
[13] Gaillard F, Campos A, Sharma R, et al. Cerebral microhaemorrhage. Reference article, Radiopaedia.org (Accessed on 17 Dec 2024) https://doi.org/10.53347/rID-4560
[14] Gaillard F, Campos A, Knipe H, et al. Canavan disease. Reference article, Radiopaedia.org (Accessed on 17 Dec 2024) https://doi.org/10.53347/rID-1045
[15] Parikh, S., Bernard, G., Leventer, R. J., van der Knaap, M. S., van Hove, J., Pizzino, A., McNeill, N. H., Helman, G., Simons, C., Schmidt, J. L., Rizzo, W. B., Patterson, M. C., Taft, R. J., & Vanderver, A. (2015). A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Molecular Genetics and Metabolism, 114(4), 501–515. https://doi.org/10.1016/j.ymgme.2014.12.434